Biomedical Research Network on Hepatic and Digestive Diseases (CIBEREHD), Instituto de Salud Carlos III, Madrid, Spain; SeLiver Group, Instituto de Biomedicina de Sevilla/Consejo Superior de Investigaciones Científicas (CSIC)/Universidad de Sevilla, Sevilla, Spain.
Biomedical Research Network on Hepatic and Digestive Diseases (CIBEREHD), Instituto de Salud Carlos III, Madrid, Spain; Gastroenterology and Hepatology Department, Ramón y Cajal Hospital/Alcalá University/IIS Ramón y Cajal (IRYCIS), Madrid, Spain.
Gastroenterol Hepatol. 2022 Nov;45(9):724-734. doi: 10.1016/j.gastrohep.2022.02.005. Epub 2022 Mar 3.
This is a meeting report of the 3rd Translational Hepatology Meeting held in Alicante, Spain, in October 2021. The meeting, which was organized by the Spanish Association for the Study of the Liver (AEEH), provided an update on the recent advances in the field of basic and translational hepatology, with a particular focus on the molecular and cellular mechanisms and therapeutic targets involved in metabolic-associated fatty liver disease (MAFLD), metabolic-associated steatohepatitis (MASH), cirrhosis and end-stage hepatocellular carcinoma (HCC).
这是 2021 年 10 月在西班牙阿利坎特举行的第三届转化肝脏学会议的会议报告。该会议由西班牙肝脏研究协会(AEEH)组织,介绍了基础和转化肝脏学领域的最新进展,特别关注代谢相关脂肪性肝病(MAFLD)、代谢相关脂肪性肝炎(MASH)、肝硬化和终末期肝细胞癌(HCC)中涉及的分子和细胞机制以及治疗靶点。